US Patent 11510888 Alleviating oxidative stress disorders with PUFA derivatives
Patent 11510888 was granted and assigned to Retrotope Inc. on November, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 30, 2019
0
Date of Patent
November 29, 2022
0
Patent Applicant
Patent Application Number
16669387
0
Patent Inventor Names
Mikhail S. Shchepinov
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11510888 Alleviating oxidative stress disorders with PUFA derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.